...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: from IR "Hepalink does not own Zenith shares."

Does anyone  know what day and time the AGM is and is there a webcast?

Share
New Message
Please login to post a reply